Albireo to Report Third Quarter 2019 Financial Results on November 6, 2019
BOSTON, Oct. 30, 2019 (GLOBE NEWSWIRE) — Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing […]
BOSTON, Oct. 30, 2019 (GLOBE NEWSWIRE) — Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing […]
FLORHAM PARK, N.J., Oct. 30, 2019 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ: CLRB), a clinical-stage biopharmaceutical company focused on the […]
MONTREAL, Oct. 30, 2019 (GLOBE NEWSWIRE) — Bombardier (TSX: BBD.B) will publish its financial results for the third quarter of […]
DENVER, Oct. 30, 2019 (GLOBE NEWSWIRE) — Enservco Corporation (NYSE American: ENSV), a diversified national provider of specialized well-site services […]
Revenue$102.5 million for 9M 2019$37.0 million for Q3 2019Cash from operating activities$24.3 million for 9M 2019$15.0 million for Q3 2019EBITDA$41.4 […]
SAN DIEGO, Oct. 30, 2019 (GLOBE NEWSWIRE) — LPL Financial Holdings Inc. (NASDAQ: LPLA) today announced that its wholly owned […]
JOHNS CREEK, Ga., Oct. 30, 2019 (GLOBE NEWSWIRE) — Ebix, Inc. (NASDAQ: EBIX), a leading international supplier of On-Demand software […]
– Study did not reach statistical significance on primary endpoint –– Positive trends on primary and secondary endpoints indicate profile […]
(1) Cash conversion is defined as Net cash provided by operating activities less Capital expenditures divided by Adjusted net income.CLEVELAND, […]
SHANGHAI, China and SAN FRANCISCO, Oct. 30, 2019 (GLOBE NEWSWIRE) — Zai Lab Limited (“Zai Lab”) (NASDAQ: ZLAB), a China […]